PPARA and metabolic disease: Synthetic PPARα ligands have been implicated in the treatment of heart failure and metabolic diseases such as hyperlipidemia and atherosclerosis due to their ability to stimulate catabolism of lipids, decrease in circulating triglycerides and to favorably alter lipoprotein metabolism [38].